These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 4182181)

  • 1. Amelioration of hypertriglyceridaemia by progestational drugs in familial type-V hyperlipoproteinaemia.
    Glueck CJ; Brown WV; Levy RI; Greten H; Fredrickson DS
    Lancet; 1969 Jun; 1(7609):1290-1. PubMed ID: 4182181
    [No Abstract]   [Full Text] [Related]  

  • 2. Norethindrone acetate, postheparin lipolytic activity, and plasma triglycerides in familial types I, 3, IV, and V hyperlipoproteinemia. Studies in 26 patients and 5 normal persons.
    Glueck CJ; Levy RI; Fredrickson DS
    Ann Intern Med; 1971 Sep; 75(3):345-52. PubMed ID: 5568147
    [No Abstract]   [Full Text] [Related]  

  • 3. Clotting mechanisms in patients with hypertriglyceridemia during therapy with anabolic or progestational drugs.
    Glueck HI; Glueck CJ
    Thromb Diath Haemorrh; 1973 May; 29(2):499-509. PubMed ID: 4762263
    [No Abstract]   [Full Text] [Related]  

  • 4. Inefficiency of cynarin as therapeutic regimen in familial type II hyperlipoproteinaemia.
    Heckers H; Dittmar K; Schmahl FW; Huth K
    Atherosclerosis; 1977 Feb; 26(2):249-53. PubMed ID: 576409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Familial hypercholesterolaemia (familial hyper-beta-lipoproteinaemia or type II hyperlipoproteinaemia) in a Chinese family.
    Teoh PC
    Singapore Med J; 1973 Jun; 14(2):124-9. PubMed ID: 4741434
    [No Abstract]   [Full Text] [Related]  

  • 6. Therapy of the hyperlipoproteinemias.
    Bagdade JD
    Acta Diabetol Lat; 1972 Dec; 9 Suppl 2():98-110. PubMed ID: 4605376
    [No Abstract]   [Full Text] [Related]  

  • 7. Management of hyperlipidemias.
    Murphy BF
    JAMA; 1974 Dec 23-30; 230(12):1683-91. PubMed ID: 4373590
    [No Abstract]   [Full Text] [Related]  

  • 8. Apolipoprotein A-V genetic variation and plasma lipoprotein response to fibrates.
    Hegele RA; Pollex RL
    Arterioscler Thromb Vasc Biol; 2007 Jun; 27(6):1224-7. PubMed ID: 17522394
    [No Abstract]   [Full Text] [Related]  

  • 9. Proceedings: Studies in the management of the climacteris.
    Moore B; Gustafson R; Studd JW
    J Obstet Gynaecol Br Commonw; 1974 Dec; 81(12):1005-6. PubMed ID: 4452919
    [No Abstract]   [Full Text] [Related]  

  • 10. Sequential mestranol and morethisterone in the treatment of the climacteric syndrome.
    Moore B
    Postgrad Med J; 1976; 52 Suppl 6():39-47. PubMed ID: 981118
    [No Abstract]   [Full Text] [Related]  

  • 11. Reduction of serum lipids in familial hyperlipidemias by a tetralin derivative.
    Oriente P; Motolese M; Cerqua R; Mancini M
    Int Z Klin Pharmakol Ther Toxikol; 1969 Oct; 2(4):348-53. PubMed ID: 4903988
    [No Abstract]   [Full Text] [Related]  

  • 12. [Estrogens, gestagens and lipid metabolism].
    Lauritzen C
    Z Ernahrungswiss Suppl; 1972; 12():Suppl 12:22-31. PubMed ID: 4505204
    [No Abstract]   [Full Text] [Related]  

  • 13. Clofibrate and related compounds in hyperlipoproteinaemia. A review.
    Gustafson A
    Postgrad Med J; 1975; 51(8):66-71. PubMed ID: 768950
    [No Abstract]   [Full Text] [Related]  

  • 14. Lipid lowering drugs and hyperlipidaemia.
    Levy RI; Rifking BM
    Drugs; 1973; 6(1):12-45. PubMed ID: 4361281
    [No Abstract]   [Full Text] [Related]  

  • 15. Familial hyperlipidemias. Diagnosis and treatment.
    Fleischmajer R; Dowlati Y; Reeves JR
    Arch Dermatol; 1974 Jul; 110(1):43-50. PubMed ID: 4371196
    [No Abstract]   [Full Text] [Related]  

  • 16. Type-III Hyperlipoproteinaemia ("remnant removal disease"). Insight into the pathogenetic mechanism.
    Chait A; Brunzell JD; Albers JJ; Hazzard WR
    Lancet; 1977 Jun; 1(8023):1176-8. PubMed ID: 68276
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Use of an estro-progestational combination in the treatment of dysfunctional pre-climacteric meno-metrorrhagias].
    De Patre P
    Minerva Ginecol; 1975 Dec; 27(12):1031-6. PubMed ID: 778678
    [No Abstract]   [Full Text] [Related]  

  • 18. Familial hyperuricaemia and hypertriglyceridaemia.
    Bennett RM; Chait A; Lewis B
    Ann Rheum Dis; 1973 Nov; 32(6):497-500. PubMed ID: 4760474
    [No Abstract]   [Full Text] [Related]  

  • 19. Therapeutic utility of norethindrone-mestranol in abnormal uterine bleeding.
    McDonough PG; Greenblatt RB
    Obstet Gynecol; 1966 Apr; 27(4):480-3. PubMed ID: 5907368
    [No Abstract]   [Full Text] [Related]  

  • 20. Plasma-triglycerides do not regulate high-density lipoprotein concentrations.
    Herbert PN; Henderson LO
    Lancet; 1979 Jun; 1(8131):1368-70. PubMed ID: 87831
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.